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Summary
Prions are a unique group of pathogens, which are considered to com-
prise solely of an abnormally folded isoform of the cellular prion protein.
The accumulation and replication of prions within secondary lymphoid
organs is important for their efficient spread from the periphery to the
brain where they ultimately cause neurodegeneration and death. Mononu-
clear phagocytes (MNP) play key roles in prion disease pathogenesis.
Some MNP appear to facilitate the propagation of prions to and within
lymphoid tissues, whereas others may aid their clearance by phagocytosis
and by destroying them. Our recent data show that an intact splenic mar-
ginal zone is important for the efficient delivery of prions into the B-cell
follicles where they subsequently replicate upon follicular dendritic cells
before infecting the nervous system. Sialoadhesin is an MNP-restricted
cell adhesion molecule that binds sialylated glycoproteins. Sialoadhesin is
constitutively expressed upon splenic marginal zone metallophilic and
lymph node sub-capsular sinus macrophage populations, where it may
function to bind sialylated glycoproteins, pathogens and exosomes in the
blood and lymph via recognition of terminal sialic acid residues. As the
prion glycoprotein is highly sialylated, we tested the hypothesis that sialo-
adhesin may influence prion disease pathogenesis. We show that after
peripheral exposure, prion pathogenesis was unaltered in sialoadhesin-
deficient mice; revealing that lymphoid sequestration of prions is not
mediated via sialoadhesin. Hence, although an intact marginal zone is
important for the efficient uptake and delivery of prions into the B-cell
follicles of the spleen, this is not influenced by sialoadhesin expression by
the MNP within it.
Keywords: complement component C4; macrophage; prion disease; sialo-
adhesin; spleen; transmissible spongiform encephalopathies.
Introduction
Prion diseases (or transmissible spongiform encephalopa-
thies) comprise a unique group of subacute, fatal, infec-
tious neurodegenerative disorders. During prion disease,
aggregations of PrPSc, an abnormally folded isoform of
the host cellular prion glycoprotein (PrPC) accumulate in
affected tissues.1 Prion infectivity co-purifies with PrPSc
and is considered to constitute the major component of
the infectious agent.2,3 The accumulation of PrPSc within
the central nervous system (CNS) of prion-infected hosts,
coincident with neuronal loss, vacuolation (spongiosis)
and reactive glial responses in both astrocytes and micro-
glia, are the major neuropathological hallmarks of prion
disease. After peripheral exposure, many prion diseases
often accumulate and replicate first in a PrPC-dependent
manner upon follicular dendritic cells (FDC) within the
B-cell follicles of secondary lymphoid organs.4,5 From
Abbreviations: CNS, central nervous system; FDC, follicular dendritic cell; IHC, immunohistochemistry; MARCO, macrophage
receptor with collagenous structure; MNP, mononuclear phagocyte; MZ, splenic marginal zone; PAP, pre-formed peroxidase–anti
peroxidase; PET, paraffin-embedded tissue; PK, proteinase K; PrP, prion protein; Sn–/–, sialoadhesin-deficient; WT, wild-type
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these tissues prions subsequently invade the CNS via
spreading through the peripheral nervous system6,7
although haematogenous spread cannot be entirely
excluded. For some prion diseases this peripheral phase
of infection may be obligatory for efficient transmission
to the CNS (termed neuroinvasion).
The precise mode by which infectious prions are ini-
tially conveyed from the site of exposure to FDC within
the B-cell follicles is uncertain; however, a number of cel-
lular and molecular components of the innate immune
system have been shown to be involved. FDC characteris-
tically trap and retain native antigen on their surfaces in
the form of immune complexes, consisting of antigen–
antibody and/or opsonizing complement components.
The FDC appear to initially trap and retain prions on
their surfaces in the form of complement-bound com-
plexes.8–10 In addition to these molecular factors, migra-
tory cells such as integrin ax-expressing (Itgax/CD11c)
mononuclear phagocytes (MNP) may also play an impor-
tant role in the initial uptake and transport of prions
because their depletion before peripheral exposure
blocked prion accumulation upon FDC and reduced dis-
ease susceptibility.11,12 Complement components may also
aid the initial uptake of prions by MNP.13
The splenic marginal zone (MZ) surrounding the white
pulp comprises a marginal sinus with a network of sinus-
lining cells and reticular cells through which the blood
percolates on its way to the red pulp. Attached to this
network are specific populations of MNP and B cells
which enable the continual surveillance and clearance of
pathogens, antigens and apoptotic cells from the blood-
stream. The positioning of these cells in the MZ enables
them to regulate the entry of blood-borne immune com-
plexes and proteoglycans into the FDC-containing B-cell
follicles.14,15 For example, in lymph nodes the sub-capsu-
lar sinus macrophages capture immune complexes on
their surfaces and pass them to follicular B cells for deliv-
ery to FDC in the B-cell follicles.16 An intact splenic MZ
also plays an important role in the efficient delivery of
complement-bound prions to FDC.17,18
Treatments that block the early accumulation and repli-
cation of prions in the spleen can block or substantially
reduce disease susceptibility.8,11,19,20 Therefore, identifica-
tion of the cellular and molecular factors that influence
the initial accumulation of prions in secondary lymphoid
tissues may reveal novel targets for therapeutic interven-
tion. Sialic acids are a large family of nine-carbon sugars
that are normally found at the terminal, exposed posi-
tions of glycans at the cell surface and on secreted pro-
teins. Sialoadhesin can bind to sialic acid residues
expressed on the surface of some important pathogens
such as porcine reproductive and respiratory syndrome
virus, HIV-1, Trypanosoma cruzi, Neisseria meningitides
and Campylobacter jejuni.21 Host-encoded sialic acid
binding immunoglobulin-like lectin (siglec) proteins are
expressed by various MNP subsets under steady-state or
are induced during inflammatory conditions and act as
cell–cell and cell–pathogen recognition and endocytic
internalization receptors.22 Sialoadhesin (siglec-1/CD169)
binds sialylated glycan end chains23 and specifically recog-
nizes N-acetylneuraminic acid (Neu5Ac), the predomi-
nant sialic acid found in mammalian cells.24 The prion
protein is variably glycosylated and extensively sialylated25
and undergoes altered sialylation during disease-associ-
ated accumulation in the CNS.26 Since MZ metallophilic
macrophages (and sub-capsular sinus macrophages in
lymph nodes) are characterized by their constitutive
expression of sialoadhesin,27 in the current study we
tested the hypothesis that sialoadhesin plays an important
role in regulating the initial delivery of prions to FDC
within the B-cell follicles.
Materials and methods
Mice
Siaoladhesin-deficient (Sn/) mice28 were bred and
maintained on a C57BL/6 background. Age-matched (5–
7 weeks old) C57BL/6 mice were used as wild-type (WT)
controls. Mice were housed under specific pathogen-free
conditions with a 12 : 12-hr light : dark cycle and food
and water were provided ad libitum. All experiments were
conducted under the provisions of the UK Animals Scien-
tific Procedures Act 1986 and approved by the University
of Edinburgh’s Ethical Review Committee.
Prion infection
Groups of Sn/ mice and WT mice were injected via
either the intracerebral or intraperitoneal route with 20 ll
of a 1% (weight/volume) brain homogenate prepared
from mice terminally infected with ME7 scrapie prions.
Mice were culled at the intervals indicated after exposure,
or observed for signs of clinical prion disease as described
elsewhere17 and culled at a standard clinical end-point.
Disease incubation periods were calculated as the interval
between injection and positive clinical assessment of ter-
minal prion disease.
Neuropathological assessment
Clinical prion disease diagnosis was confirmed by histo-
pathological assessment of vacuolation (spongiform
pathology) in the brain. Brain tissues were fixed in 10%
formal saline for a minimum of 48 hr, then processed
and embedded in paraffin. Sections (6 lm in thickness)
were cut and stained with haematoxylin & eosin and
scored for spongiform vacuolar degeneration. For the
construction of lesion profiles, vacuolar changes were
scored in several grey matter and white matter areas of
ª 2014 The Authors. Immunology published by John Wiley & Sons Ltd., Immunology, 143, 120–129 121
Effect of sialoadhesin-deficiency on prion pathogenesis
each brain, as described previously.29 Briefly, mouse brain
coronal sections were scored for the presence and severity
(scale 0–5) of prion-disease-specific vacuolation in nine
grey matter and three white matter brain areas: G1, dorsal
medulla; G2, cerebellar cortex; G3, superior colliculus;
G4, hypothalamus; G5, medial thalamus; G6, hippocam-
pus; G7, septum; G8, cerebral cortex; G9, forebrain cere-
bral cortex; W1, cerebellar white matter; W2, midbrain
white matter; W3, cerebral peduncle.
Passive immunization
To assess antigen trapping in vivo, mice were passively
immunized by intravenous injection with 100 ll pre-
formed peroxidase–anti peroxidase (PAP) immune com-
plexes (Sigma, St Louis, MO) as described4 or 70 000
molecular weight dextran-FITC (Sigma) as described pre-
viously.30 To prepare fluorescently labelled PrPSc (Alexa-
PrPSc), PrPSc was enriched from the brains of mice termi-
nally affected with ME7 scrapie prions and labelled as
described previously.31,32
Immunohistochemical analysis
Tissues were fixed in periodate–lysine–paraformaldehyde
fixative and embedded in paraffin wax. Sections (thick-
ness 6 lm) were deparaffinized, pre-treated by autoclav-
ing in water at 121° for 15 min, and immersed in 98%
formic acid for 10 min. Sections were incubated over-
night with primary antibody. For the detection of astro-
cytosis, rabbit anti-glial fibrillary acidic protein (Dako,
Glostrup, Denmark); for microgliosis, rabbit anti-AIF1/
Iba1 (Wako, Richmond, VA); for disease-specific PrP
(PrPd) in brain, mouse anti-PrP clone 6H4 (Prionics,
Schlieren-Zurich, Switzerland); and for spleen, rabbit
polyclonal anti-PrP 1B3.33 Antibody binding was detected
using biotinylated goat anti-species specific antibodies
(Jackson Immunoresearch, West Grove, PA) and visual-
ized using the Elite ABC/HRP kit (Vector Laboratories,
Peterborough, UK) and diaminobenzidine (DAB) or Nov-
aRed (Vector Laboratories) between stringent washing
steps. Sections were lightly counterstained with haemat-
oxylin and imaged on an E800 microscope (Nikon) using
IMAGE PRO PLUS (Media Cybernetics, Rockville, MD) soft-
ware. Paraffin-embedded tissue (PET) immunoblot analy-
sis was used to confirm that the PrPd detected by
immunohistochemistry (IHC) was prion disease-specific
proteinase K (PK)-resistant PrPSc.34
For the detection of other markers, additional immuno-
stainings were performed on fixed or frozen sections using
the following antibodies: biotin anti-mouse MAdCAM-1
(clone MECA-367; BioLegend, San Diego, CA); CD45RO-
B220:allophycocyanin (Clone RA3-6B2; BioLegend);
CD169:Alexa488 (Clone MOMA-1; AbD Serotec, Raleigh,
NC); rat anti-C4 (Clone FDC-M2; AMS Biotechnology,
Abingdon, UK); rat anti-CD21/35 [CR1/CR2] (clone 7G6;
BD Pharmingen, Franklin Lakes, NJ). Rat anti-CD35
[CR1] (clone 8C12; BD Pharmingen); Armenian hamster
anti-CD209b/SIGNR-1 (clone 22D1; eBioscience, San
Diego, CA) or rat anti-SIGNR-1:Alexa647 (clone ER-TR9;
AbD Serotec); rat anti-MARCO (clone ED31; AbD Sero-
tec); rabbit polyclonal anti-PrP 1B3; PAP complexes were
visualized using AlexaFluor 488-conjugated goat anti-rab-
bit IgG. The following species-specific secondary antibod-
ies, were used: anti-Armenian hamster, anti-rabbit and
anti-mouse all raised in goat or streptavidin; all Alexa-
Fluor 488, -594 or -647 conjugates (Invitrogen, Paisley,
UK); DyLightTM 649 goat anti-rat IgG (Clone Poly4054;
Biolegend). Sections were mounted in fluorescent mount-
ing medium (DakoCytomation, Glostrup, Denmark) and
examined using a Zeiss LSM5 confocal microscope
(Zeiss). Image analysis was performed using IMAGEJ soft-
ware (http://imagej/nih.gov/ij) on a minimum of six ani-
mals per group and six observations per animal, for 72
individual images analysed per comparison.
Statistical analysis
Statistical analyses were performed using MINITAB 16 soft-
ware (Minitab Ltd., Coventry, UK). Incubation period
and immunofluorescence analysis quantification data were
tested for equal variances and analysed by two-sample
t-test. Vacuolation profile data were analysed via analysis
of variance and grouped via Tukey’s post hoc testing.
Results
Effect of sialoadhesin-deficiency on FDC status and
function
In the spleens of WT mice, high levels of sialoadhesin
expression were detected only in association with the inner
MZ metallophilic macrophages surrounding the white pulp
(Fig. 1a) and their counterparts, the sub-capsular sinus
macrophages, in lymph nodes (Fig. 1c). As anticipated,
these MNP populations lacked sialoadhesin expression in
tissues from sialoadhesin-deficient mice (Fig. 1b,d). As
prion replication upon PrPC-expressing FDC is important
for efficient neuroinvasion, we next determined whether
sialoadhesin-deficiency affected FDC status or function.
FDC characteristically express high levels of complement
receptor 1 (CR1/CD35) on their surfaces. IHC analysis sug-
gested that sialoadhesin-deficiency had no observable effect
on the expression of CR1 by FDC in the spleen (Fig. 1e,f).
Morphometric analysis also suggested that size of the FDC
networks was similar in the spleens of mice from each
group (Fig. 1g, n = 6 mice per group, P = 0257). These
data are consistent with the expression of negligible levels
of the Siglec1 gene (which encodes sialoadhesin) by FDC in
contrast to MNP (see Supporting information, Fig. S1).
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The FDC trap and retain complement component C4
on their surfaces and express high levels of cellular PrPC
(Fig. 1h). These characteristics are important for the
retention and replication of prions upon the surfaces of
FDC.4,8–10 IHC revealed that significantly more comple-
ment component C4 was detected on the surfaces of FDC
in the spleens of Sn/ mice when compared with WT
controls (Fig. 1i,j; n = 6 per group, P < 0001). This
coincided with a significant reduction in the ability of
cells in the MZ of sialoadhesin-deficient mice to trap
complement component C4 (Fig. 1i,j, n = 6 mice per
group, P < 00001). Data suggest that the trapping of
immune complexes by FDC up-regulates their expression
of PrPC.35 Here, the increased association of C4 on the
surfaces of FDC in the spleens of Sn/ mice coincided
with a significant increase in the expression of PrPC upon
their surfaces (Fig. 1k; n = 6 mice per group, P < 00001)
implying a similar relationship.
To determine whether sialoadhesin-deficiency influ-
enced the trapping and retention of immunoglobulin/
antigen-containing immune complexes by FDC, mice
from each group were passively immunized with PAP
immune complexes, and 24 hr later, the presence of
FDC-associated immune complexes was identified by IHC
(Fig. 2a). Although FDC from each group retained high
levels of PAP immune complexes, a small but significant
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Figure 1. Effect of sialoadhesin-deficiency on
follicular dendritic cell (FDC) status. Splenic
marginal zone (a) and lymph node sub-capsu-
lar sinus macrophages (c) express high levels
of sialoadhesin (green) in wild-type (WT)
mice, whereas sialoadhesin is undetectable in
the spleen (b) and lymph nodes (d) of siaload-
hesin-deficient (Sn/) mice. Sections were
also immunostained to detect B cells (B220+
cells, blue). Immunostaining with anti-CD35
(e, f, red) revealed that sialoadhesin-deficiency
had no effect on FDC network size (g). Com-
parison of sialoadhesin (blue), complement
component C4 (green) and PrPC-expression
(red) in the spleens of WT (h) and Sn/ (i)
mice. In the spleens of Sn/ mice, morpho-
metric analysis revealed significant increases in
the level of complement component C4 on the
surfaces of FDC (j) and their expression of
PrPC (k) when compared with WT mice.
*P < 0001; **P < 00001.
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reduction was observed in the spleens of Sn/ mice
(Fig. 2b; n = 6 mice per group, P = 0032).
Effect of sialoadhesin-deficiency on the lectin-
mediated endocytic uptake of polysaccharides by MZ
macrophages
Mononuclear phagocytes in the MZ play important roles
in the uptake and clearance of particulate antigens from
the bloodstream. Situated within the outer layer of the
MZ are a ring of macrophage receptor with collagenous
structure (MARCO) -expressing MZ macrophages,
whereas the sialoadhesin-expressing MZ metallophilic
macrophages form a continuous inner ring close to the
white pulp. MARCO-expressing MZ macrophages also
express an array of scavenger receptors including scaven-
ger receptor-A (SR-A) and the C-type lectin SIGNR1,14
which recognize specific carbohydrate structures such as
bacterial capsular polysaccharides. We next determined
whether the phagocytosis of polysaccharide antigens by
MARCO-expressing MZ macrophages was influenced by
sialoadhesin-deficiency. Mice from each group were pas-
sively immunized with fluorescently labelled dextran par-
ticles (dextran-FITC) and spleens were analysed 1 hr later
by IHC. No differences in MARCO expression by MZ
macrophages or in their ability to endocytose dextran
within the MZ were observed between spleens of WT and
Sn/ mice (Fig. 2c). In spleens from each mouse group
the majority of the dextran-FITC was typically co-local-
ized with MARCO-expressing macrophages within the
outer layer of the MZ (Fig. 2d) with lesser amounts being
observed within the red pulp and occasionally within fol-
licular B-cell areas as was described previously.30 These
data demonstrate that sialoadhesin-deficiency does not
affect the ability of MARCO-expressing MZ macrophages
to clear blood-borne dextran particles (Fig. 2d).
Effect of sialoadhesin-deficiency on the early
accumulation of PrPSc in the spleen
Within weeks after peripheral exposure, ME7 scrapie pri-
ons accumulate first upon FDC in the secondary lym-
phoid organs and are maintained at high levels for the
duration of the disease. We next determined the effect of
sialoadhesin-deficiency on the initial accumulation of pri-
ons upon FDC in the spleen. In this study, the normal
cellular form of the prion protein is referred to as PrPC
and two distinct terms (PrPSc and PrPd) are used to
describe the disease-specific, abnormal accumulations of
PrP that are characteristically found only in prion-
affected tissues. Prion disease-specific PrP accumulations
are relatively resistant to PK digestion, whereas cellular
PrPC is destroyed. As a consequence, PK-resistant PrP
(referred to as PrPSc) can be used as a biochemical mar-
ker for the presence of prions.36 Since PK-treatment is
not suitable for use on histological sections, we refer to
these abnormal, disease-specific PrP accumulations as
PrPd. On histological sections, to confirm the presence of
prion-specific PK-resistant PrPSc, adjacent tissue sections
were applied to nitrocellulose membrane, treated with
PK, and analysed by PET immunoblot.34
Mice were injected intraperitoneally with ME7 scrapie
prions and tissues were collected at intervals after expo-
sure. Heavy PrPd accumulations, consistent with localiza-
tion upon FDC, were detected by IHC in the spleens of
all WT mice at 5 weeks after prion exposure (Fig. 3a). By
10 and 15 weeks after intraperitoneal injection with pri-
ons, the levels of PrPd upon the surfaces of FDC appeared
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Figure 2. Effect of sialoadhesin-deficiency on
passive immune complex trapping upon follic-
ular dendritic cells (FDC) and lectin-mediated
endocytic uptake in the marginal zone (MZ).
(a, b) Effect of sialoadhesin-deficiency on the
ability of FDC to trap pre-formed peroxidase–
anti-peroxidase (PAP) immune complexes.
Sections were immunostained to detect FDC
(CD35+ cells, red) and PAP (rabbit IgG,
green). (c, d) The trapping of dextran-FITC
within the splenic MZ is unaltered in siaload-
hesin-deficient (Sn/) mice.
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to have increased, and were maintained for the duration
of the disease. PET immunoblot analysis of adjacent tis-
sue sections (Fig. 3b) and immunoblot analysis of tissue
homogenates (Fig. 3c) confirmed that the PrPd detected
in these tissues was prion disease-specific PrPSc. Similarly,
high levels of PrPSc were also detected in association with
FDC in the spleens of Sn/ mice analysed at the same
times after exposure to prions (Fig. 3). These data show
that sialoadhesin-deficiency did not impair the early accu-
mulation of PrPSc upon FDC.
A parallel experiment was also performed to determine
whether sialoadhesin-deficiency influenced the accumula-
tion of prion-specific PrPSc within the spleen. Highly
PrPSc-enriched, scrapie-associated fibrils were isolated
from the brains of clinical prion disease-affected mice
and fluorescently labelled as described previously.31,32
This labelling enabled the visualization of Alexa-PrPSc in
tissues by immunofluorescence confocal microscopy.31,32
Mice from each group were injected intravenously
with Alexa-PrPSc; spleens were collected 1 hr later and
50 000
36 000
22 000
16 000
WT Sn–/– WT Sn–/– WT Sn–/–
35 dpi 70 dpi 105 dpi
WT Sn–/–
500 µm
10
5 
dp
i
RP
MZ
100 µm100 µm
100 µm
100 µm
WT Sn–/–
WT Sn–/– Sn–/–
WP WP
WPWP
MZ
RP
RP
MZ
WP
MZ
MZ
MZ
35
 d
pi
70
 d
pi
10
5 
dp
i
SI
G
NR
1/
Al
ex
a
-P
rP
SC
CD
35
/A
le
xa
-P
rP
SC
(a) (b)
(c)
(d) (e)
Figure 3. Effect of sialoadhesin-deficiency on prion accumulation in the spleen. (a) Immunohistochemical detection of prion-specific abnormal
PrP (PrPd, brown, arrows) upon follicular dendritic cell (FDC) in the spleens of wild-type (WT) and sialoadhesin-deficient (Sn/) mice. Sec-
tions counterstained with haematoxylin (blue). dpi, days post-injection with prion. (b) Paraffin-embedded tissue immunoblot analysis confirmed
the presence of prion-specific, proteinase K (PK) -resistant PrPSc (black) upon FDC (arrows). (c) Immunoblot analysis of PK-treated spleen tissue
homogenates confirmed the accumulation of high levels of prion-specific, PK-resistant PrPSc. After PK treatment, a typical three-band pattern
was observed between molecular mass values of 20–30 000 MW, representing unglycosylated, monoglycosylated and diglycosylated isomers of
PrP (in order of increasing molecular mass). Approximate molecular weight markers are indicated. (d, e) Analysis of spleen sections from Alexa-
PrPSc-injected mice suggested that the PrPSc (red) was mostly associated with SIGNR1+ marginal zone (MZ) macrophages (d, blue, arrows), and
occasionally in the red pulp (RP) and white pulp (WP; d, arrowheads) in regions in close association with CR1/CD35-expressing (green) FDC (e,
arrows). No apparent differences were observed between tissues from WT or Sn/ mice. Dashed lines indicate the border of the MZ.
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immunostained to detect the SIGNR-1-expressing MZ
macrophages. No differences in SIGNR-1 expression by
MZ macrophages and in the anatomical localization of
Alexa-PrPSc between spleens of WT and Sn/ mice were
observed. The majority of the Alexa-PrPSc was observed
within the MZ (Fig. 3d, arrows), but small amounts were
observed in the white pulp (Fig. 3d, arrowheads) occa-
sionally in close association with FDC (Fig. 3e, arrows).
Effect of sialoadhesin-deficiency on prion disease
susceptibility
We next determined whether sialoadhesin-deficiency
influenced prion neuroinvasion or disease susceptibility.
Our data show that sialoadhesin-deficiency had no signif-
icant effect on the spread of prions to the brain after
intraperitoneal injection as all WT and Sn/ mice suc-
cumbed to clinical prion disease with similar incubation
periods (Table 1, P = 0130). Similarly, when WT and
Sn/ mice were injected with prions directly into the
CNS by intracerebral injection, they developed clinical
prion disease with similar incubation periods (Table 1,
P = 0717). Histopathological analysis confirmed that
brains from all clinically affected WT and Sn/ mice dis-
played the characteristic spongiform pathology, astroglio-
sis, microgliosis and PrPd accumulation typically
associated with terminal infection with ME7 scrapie pri-
ons (Fig. 4). Together, these data reveal no significant
effect of sialoadhesin-deficiency on prion neuroinvasion
or disease susceptibility.
Discussion
Prion replication upon FDC in secondary lymphoid
organs is critical for their efficient neuroinvasion.4,19,20
However, as FDC are non-motile, stromal-derived cells
which form networks in the B-cell follicles37,38 it is uncer-
tain how prions are first conveyed to secondary lymphoid
tissues and transferred to FDC. Both cell-associated and
cell-free mechanisms have been suggested.8–10,39 The sple-
nic MZ is a specialized microenvironment that plays an
important role in the capture and clearance of blood-
borne pathogens/antigens. Specific populations of MNP
within the MZ (and sub-capsular sinus of lymph nodes)
have also been shown to capture immune complexes and
present them to follicular B cells for delivery to
FDC.15,16,40 The opsonization of prions with complement
components is important for their retention by FDC.8–10
In studies elsewhere we have also shown that an intact
MZ is also important for the initial localization of prions
upon FDC.17,18 These data imply that a similar cellular
relay may shuttle complement-opsonized prions to FDC.
The prion protein is highly sialylated,25 and MZ metallo-
philic macrophages in the spleen, and the sub-capsular
sinus macrophages in the lymph nodes, constitutively
express high levels of sialoadhesin, which binds to sialy-
lated glycoproteins.27 Prions may also be released from
infected cells in association with exosomes and play an
important role in their cell-to-cell transmission.41,42 A
role for MNP-expressed sialoadhesin in the capture of B-
cell-derived exosomes in the spleen and lymph nodes via
surface expressed sialic acids has also been described.43
The identification of molecular factors that influence the
initial accumulation of prions in secondary lymphoid tis-
sues may reveal novel targets for therapeutic intervention.
Therefore, in the current study we used Sn/ mice to
test the hypothesis that sialoadhesin-expressing MNP in
the MZ play an important role in the initial uptake of
prions in the spleen. However, our data show that after
peripheral prion disease exposure the early accumulation
of PrPSc on FDC, subsequent neuroinvasion and disease
susceptibility were not impaired in Sn/ mice. Hence,
these data show that the efficient delivery of prions to
FDC in the spleen is not influenced by sialoadhesin-
expression by MZ metallophilic MNP. These data do not
preclude the possibility that MZ metallophilic macro-
phages may be involved in prion uptake and transfer into
the B-cell follicles, only that sialoadhesin itself is non-
essential for this process.
In WT mice high levels of activated complement com-
ponent C4 were detected in association with FDC, which
is indicative of the retention of complement-opsonized
Table 1. Effect of sialoadhesin-deficiency on prion disease susceptibility
Route of prion exposure
Intracerebral injection Intraperitoneal injection
Mouse strain
Incidence of
clinical disease1
Mean incubation
period (days)  SEM
Incidence of
clinical disease
Mean incubation period
(days)  SEM
WT 5/5 153  4 8/8 241  7
Sn/ 6/6 151  4 6/6 256  6
Abbreviations: Sn/, sialoadhesin-deficient; WT, wild-type.
1Number of mice affected/injected with prions.
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immune complexes on their surfaces.44 However, low
levels were also detected in association with the MZ.
Studies elsewhere show that in the absence of effective
immune-complex shuttling from the MZ to FDC, MZ B
cells appear unable to ‘off-load’ their complement-opson-
ized antigens, resulting in their increased accumulation of
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Figure 4. Effect of sialoadhesin-deficiency on
the neuropathology in the brains of prion-
infected mice. (a) Sialoadhesin-deficiency had
no observable effect on disease-specific vacuo-
lation, PrPd deposition, or reactive glial
responses in the brains of the clinically
affected, peripheral prion-infected mice. High
levels of spongiform pathology (haematoxylin
& eosin, top row), heavy accumulations of dis-
ease-specific prion protein (PrP) (brown, sec-
ond row), reactive astrocytes expressing glial
fibrillary acidic protein (GFAP) (brown, third
row), and active microglia expressing Iba1
(brown, bottom row) were detected in the
brains of all clinically prion disease-affected
wild-type (WT) mice (left-hand column) and
sialoadhesin-deficient (Sn/) mice (right-hand
column). (b) Pathological assessment of the
spongiform change (vacuolation) in brains
from terminally prion-affected WT (blue line)
and Sn/ (red line) mice. Vacuolation was
scored on a scale of 0–5 in the following grey
(G1–G9) and white (W1–W3) matter areas:
G1, dorsal medulla; G2, cerebellar cortex; G3,
superior colliculus; G4, hypothalamus; G5,
thalamus; G6, hippocampus; G7, septum; G8,
retrosplenial and adjacent motor cortex; G9,
cingulate and adjacent motor cortex; W1, infe-
rior and middle cerebellar peduncles; W2,
decussation of superior cerebellar peduncles;
and W3, cerebellar peduncles.
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complement component C4.15,45,46 In the spleens of Sn/
 mice the MZ localization of complement component
C4 was significantly reduced. Furthermore, this coincided
with a significant increase in complement component C4
upon FDC in the spleens of Sn/ mice (Fig. 1). Glycan
profiling of complement component C4 has revealed that
it carries a mixture of both oligomannose and complex
bi-antennary glycans with varying amounts of sialyla-
tion.47 These data suggest that sialoadhesin may play an
important role in the initial uptake and sequestration of
blood-borne complement-opsonized immune complexes
by MZ metallophilic macrophages via terminal sialic acid
residues on the glycans on complement component C4.
Our data also suggest that in the absence of this activity
in Sn/ mice, less complement component C4 is seques-
tered by MNP in the MZ, enabling more to be shuttled
to FDC. The retention of immune complexes on FDC
promotes the ability of naive IgM+ B cells to mature and
class switch to high-affinity IgG.48 Whether the signifi-
cantly reduced IgM titre in the serum of Sn/ mice28 is
a consequence of the effects of sialoadhesin-deficiency on
complement component C4 retention is uncertain.
The expression of PrPC by FDC has been shown to be
stimulated by their retention of complement-opsonized
immune complexes, and this up-regulation in PrPC-
expression is blocked in mice that are deficient in com-
plement component C1q.35 Conversely, the dramatically
impaired retention of immune complexes by FDC in aged
mice coincides with substantially reduced levels of PrPC
expression.17,18,49 In the current study, coincident with
the increased accumulation of complement component
C4, the level of PrPC expressed by FDC was also signifi-
cantly increased, implying complement-mediated up-reg-
ulation of PrPC-expression by FDC.
Prions are considered to be initially acquired by FDC
as complement-opsonized immune complexes.4,8–10 In the
absence of sialoadhesin expression by metallophilic mac-
rophages the retention of complement component C4
upon FDC was increased. Hence, it is plausible that in
the spleens of Sn/ mice fewer complement-opsonized
prions were sequestered by MNP in the MZ, enabling
them to be shuttled more efficiently to FDC.
In summary, despite the important role of sialoadhesin
in the binding of sialylated antigens21–24 and exosomes,43
our data show that after peripheral prion exposure sialo-
adhesin expression by metallophilic macrophages in the
inner ring of the splenic MZ is not required for the effi-
cient transport of prions to FDC and the subsequent
spread of disease to the CNS. Treatments that block the
early accumulation of prions upon FDC can block or
substantially reduce disease susceptibility.8,11,19,20 There-
fore, identification of the cellular and molecular factors
that influence the initial delivery of prions to FDC in the
B-cell follicles of secondary lymphoid tissues may reveal
novel targets for therapeutic intervention in peripherally
acquired infections, or factors that influence disease sus-
ceptibility.
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